As of 2025-07-03, the EV/EBITDA ratio of Acceleron Pharma Inc (XLRN) is -41.25. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Acceleron's latest enterprise value is 10,456.47 mil USD. Acceleron's TTM EBITDA according to its financial statements is -253.46 mil USD. Dividing these 2 quantities gives us the above Acceleron EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.7x - 12.4x | 10.6x |
| Forward P/E multiples | 11.5x - 18.9x | 11.9x |
| Fair Price | (42.70) - (46.31) | (41.65) |
| Upside | -123.9% - -125.9% | -123.3% |
| Date | EV/EBITDA |